Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%
Phase of Trial: Phase I
Latest Information Update: 10 Sep 2016
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis; Skin cancer
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 02 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jan 2014 According to ClinicalTrials.gov record trial status changed from recruiting to active, no longer recruiting.
- 08 Jul 2013 New trial record